ARTICLE | Financial News
Actelion Ltd. (SIX:ATLN) added CHF20.70 (10%) to CHF218.20 on Friday after media reports said Sanofi (Euronext:SAN; NYSE:SNY) was nearing a deal to acquire the Swiss biotech. Actelion shares have now risen 38% since closing at CHF158 on Nov. 24, before rumors of a takeout began to circulate (see BioCentury Extra, Nov. 28).
Johnson & Johnson (NYSE:JNJ) said late Tuesday it had ended discussions with Actelion about a potential deal. Actelion revealed early Wednesday that it was negotiating with another bidder (see BioCentury Extra, Dec. 14)...